Long-term therapy for rheumatoid arthritis

[1] CASH JM, 1994, NEW ENGL J MED, V330, P1368

[2] SURVIVAL ANALYSIS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN SPANISH RHEUMATOID-ARTHRITIS PATIENTS [J]. ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (11) : 881 - 885

[3] USE OF SHORT-TERM EFFICACY TOXICITY TRADEOFFS TO SELECT 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - A METAANALYSIS OF PUBLISHED CLINICAL-TRIALS [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1117 - 1125

[4] Hawley D J, 1992, Arthritis Care Res, V5, P130, DOI 10.1002/art.1790050304

[5] HAWLEY DJ, 1991, J RHEUMATOL, V18, P1008

[6] LEIGH JP, 1992, J RHEUMATOL, V19, P1906

[7] PAULUS HE, 1994, J RHEUMATOL, V21, P8

[8] RHEUMATOID-ARTHRITIS - DISAPPOINTING LONG-TERM OUTCOMES DESPITE SUCCESSFUL SHORT-TERM CLINICAL-TRIALS [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (11) : 1037 - 1041

[9] PINCUS T, 1995, RHEUM DIS CLIN N AM, V21, P619

[10] OUTCOME OF 2ND LINE THERAPY IN RHEUMATOID-ARTHRITIS [J]. ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (12) : 812 - 815

[1] CASH JM, 1994, NEW ENGL J MED, V330, P1368

[2] SURVIVAL ANALYSIS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN SPANISH RHEUMATOID-ARTHRITIS PATIENTS [J]. ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (11) : 881 - 885

[3] USE OF SHORT-TERM EFFICACY TOXICITY TRADEOFFS TO SELECT 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - A METAANALYSIS OF PUBLISHED CLINICAL-TRIALS [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1117 - 1125

[4] Hawley D J, 1992, Arthritis Care Res, V5, P130, DOI 10.1002/art.1790050304

[5] HAWLEY DJ, 1991, J RHEUMATOL, V18, P1008

[6] LEIGH JP, 1992, J RHEUMATOL, V19, P1906

[7] PAULUS HE, 1994, J RHEUMATOL, V21, P8

[8] RHEUMATOID-ARTHRITIS - DISAPPOINTING LONG-TERM OUTCOMES DESPITE SUCCESSFUL SHORT-TERM CLINICAL-TRIALS [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (11) : 1037 - 1041

[9] PINCUS T, 1995, RHEUM DIS CLIN N AM, V21, P619

[10] OUTCOME OF 2ND LINE THERAPY IN RHEUMATOID-ARTHRITIS [J]. ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (12) : 812 - 815